Ignite Creation Date:
2024-07-17 @ 11:41 AM
Last Modification Date:
2025-12-17 @ 8:28 AM
Study NCT ID:
NCT06492083
Status:
None
Last Update Posted:
2025-02-17 00:00:00
First Post:
2024-06-18 00:00:00
Brief Title:
A Stuty on the Treatment and Nursing Care of CIPN Patients With Traditional Chinese Medicine Hot Package
Sponsor:
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Organization:
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Study Overview
Official Title:
A Randomized Controlled Clinical Stuty on the Treatment and Nursing Care of CIPN Patients With Traditional Chinese Medicine Hot Package
Status:
None
Status Verified Date:
2025-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A random group generator was used to divide the sample of 90 cases, and 45 cases in the control group and 45 cases in the intervention group.
Control group: The chemotherapy was strictly followed by the drug use routine, administered by central vein, paclitaxel and platinum administration rate were set at 180ml/h, and routine health guidance was given before and after chemotherapy.
Intervention group: In addition to the usual nursing measures of the control group, traditional Chinese medicine hot bao acupoint treatment and home care were used.
Patients in both the intervention and control groups were assessed for peripheral neuropathy on the 14th day after the completion of each two rounds of chemotherapy, and the NCI-CTCAE, FACT/GOG-Ntx, and KPSS score scales were assigned according to the patient-reported outcomes.
Control group: The chemotherapy was strictly followed by the drug use routine, administered by central vein, paclitaxel and platinum administration rate were set at 180ml/h, and routine health guidance was given before and after chemotherapy.
Intervention group: In addition to the usual nursing measures of the control group, traditional Chinese medicine hot bao acupoint treatment and home care were used.
Patients in both the intervention and control groups were assessed for peripheral neuropathy on the 14th day after the completion of each two rounds of chemotherapy, and the NCI-CTCAE, FACT/GOG-Ntx, and KPSS score scales were assigned according to the patient-reported outcomes.
Detailed Description:
A random group generator was used to divide the sample of 90 cases and 45 cases in the control group and 45 cases in the intervention group
Control group The chemotherapy was strictly followed by the drug use routine administered by central vein paclitaxel and platinum administration rate were set at 180mlh and routine health guidance was given before and after chemotherapy
Intervention group In addition to the usual nursing measures of the control group traditional Chinese medicine hot bao acupoint treatment and home care were used
Patients in both the intervention and control groups were assessed for peripheral neuropathy on the 14th day after the completion of each two rounds of chemotherapy and the NCI-CTCAE FACTGOG-Ntx and KPSS score scales were assigned according to the patient-reported outcomes
Control group The chemotherapy was strictly followed by the drug use routine administered by central vein paclitaxel and platinum administration rate were set at 180mlh and routine health guidance was given before and after chemotherapy
Intervention group In addition to the usual nursing measures of the control group traditional Chinese medicine hot bao acupoint treatment and home care were used
Patients in both the intervention and control groups were assessed for peripheral neuropathy on the 14th day after the completion of each two rounds of chemotherapy and the NCI-CTCAE FACTGOG-Ntx and KPSS score scales were assigned according to the patient-reported outcomes
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None